MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Thrasos Announces Successful Formal Interim Analysis and Clinical Update.
Guest UserSeptember 16, 2014
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy.

Guest UserOctober 28, 2014
Next

Janssen Affiliate Cilag GmbH International Acquires Covagen AG.

Guest UserAugust 25, 2014

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact